Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. - Wikidata - wikimedia - TriplyDB

Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.

Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.

http://www.wikidata.org/entity/Q35038416

about

Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Can microfluidics address biomanufacturing challenges in drug/gene/cell therapies?Targeted nanotechnology for cancer imaging.Cancer nanomedicine: from targeted delivery to combination therapy Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixer Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Organ-on-a-chip platforms for studying drug delivery systems.Polymeric nanoparticle technologies for oral drug delivery.Shape-controlled synthesis of hybrid nanomaterials via three-dimensional hydrodynamic focusing.Systems approaches to design of targeted therapeutic delivery.Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies.Control of polymeric nanoparticle size to improve therapeutic delivery.Polymeric nanoparticle drug delivery technologies for oral delivery applications.Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.Production of nanoparticle drug delivery systems with microfluidics tools.Personalized medicine in hematology - A landmark from bench to bed Self-assembly via microfluidics.Molecular imprinting: perspectives and applications.Nanomedicines for renal disease: current status and future applications Microfluidic Synthesis of Nanoparticles and their Biosensing Applications.Microprocessor-based integration of microfluidic control for the implementation of automated sensor monitoring and multithreaded optimization algorithms.Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.Biomaterials in siRNA Delivery: A Comprehensive Review.Continuous microfluidic assembly of biodegradable poly(beta-amino ester)/DNA nanoparticles for enhanced gene delivery.Controllable synthesis of functional nanoparticles by microfluidic platforms for biomedical applications - a review.Microfluidic-assisted fabrication of carriers for controlled drug delivery.A cooperative polymeric platform for tumor-targeted drug delivery.Enriching Nanoparticles via Acoustofluidics In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.Recent advances of controlled drug delivery using microfluidic platforms.Why microfluidics? Merits and trends in chemical synthesis.Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems.PEGylated crosslinked hyaluronic acid nanoparticles designed through a microfluidic platform for nanomedicine.Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials.Hydrogel microfluidic co-culture device for photothermal therapy and cancer migration.Microfluidics-based 3D cell culture models: Utility in novel drug discovery and delivery research.A versatile and robust microfluidic platform toward high throughput synthesis of homogeneous nanoparticles with tunable properties.Optimizing the discovery and clinical translation of nanoparticles: could microfluidics hold the key?PLGA-Based Nanoparticles in Cancer Treatment

P2860

Q26740363-846E0DD9-ABFB-492B-80C2-7B39716E8E28 Q26752073-4D69EE33-9B15-4819-8640-8FAB777F4BE3 Q27010317-EE0A465A-4778-4735-9496-568CBD67909D Q28083065-0C2F7CD0-E565-4CB1-ADC0-F2375E907E91 Q30581724-A036C6F6-BBF2-4F62-A631-4CF90DD22613 Q33902253-E87B17B5-831D-408E-B03D-EF704A5A9190 Q34079592-CD5D4B2E-6F5A-4B41-9359-4A9E6261E49C Q34225096-8285BB98-94BF-45EA-A65B-5314F74EF9BE Q34419946-0AC50B15-7988-45D5-B425-94DA8163587C Q35623160-5998A42A-7772-4F78-85E5-1214E4C1C642 Q35787096-A1895E21-E4F9-49DB-835A-2EBBA7AAD6C9 Q36307555-00FDAF86-52F6-4562-A870-003AA6347AF4 Q36808308-55659A27-71F1-48ED-B9DD-F40BF22B4B41 Q37544674-7683EE47-8D00-40C0-98D8-E60053775D94 Q38262775-402251FF-485E-4548-8EDC-7FAF2E0C1E6A Q38263199-866E7866-2304-4AA2-AD89-F8EBF6B1284F Q38675698-ED7F3CCC-5686-4734-97BB-DCFADFFC6E45 Q38758535-49A33E9E-DB18-49D2-BFD4-32C519F1B16F Q38802375-7C3A27CA-8F25-4B2F-9CEE-548A71C94095 Q38806278-86694438-0C05-43E5-8354-3FE771F1F592 Q38847754-FD151E3C-54D8-4531-9543-CEFFF8022CB3 Q38957484-703F14FE-BC71-4F7F-B511-49361791E472 Q38971775-59954F5C-5B52-4470-86A3-D999CCE46530 Q38972245-ED427A14-1CA3-4D4B-8205-9E363540C54E Q39043037-385858ED-8F63-43C6-A632-1DD0BFA16EE2 Q39289983-66543E12-E33C-4A36-8DDA-1A0F8C89264B Q41144001-E09B9E37-859F-4A4E-9E15-7CCF963EF4D3 Q41189988-84D7E6EB-9BD5-4685-87A6-6CE4D82EEC1C Q41502965-FF69670A-1983-4538-A9DD-6359DDB41769 Q42145728-127DAE7B-2B15-4E67-BFD6-C9170DB4EE58 Q47666014-725471C4-6497-47CE-815A-1D527947A253 Q47673030-087E61BA-D734-4753-8422-6D21857A0056 Q47690085-641D7897-A689-4250-A5C8-312C82BA2375 Q47787964-88A42C78-2C26-425F-BA4D-5D5F391C2B86 Q50046520-15D825C2-BAC0-485A-92F1-722512738C03 Q51014515-36FD0884-E10C-4C55-9568-2CEB96226438 Q51459366-5C314070-71B2-4A2F-9950-9BD38CA196E7 Q51499008-1E5B35A8-41C9-4BBA-991A-A025624C4B6C Q51510602-E80DC928-D16C-4FB4-9EC8-DBE6F8EEED14 Q59137460-F223F363-5F2C-450A-A4BC-5EB9E0A55EE5

P2860

Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.

http://www.wikidata.org/entity/Q35038416

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Microfluidic platform for comb ...... oparticles for cancer therapy.

@ast

Microfluidic platform for comb ...... oparticles for cancer therapy.

@en

type

label

Microfluidic platform for comb ...... oparticles for cancer therapy.

@ast

Microfluidic platform for comb ...... oparticles for cancer therapy.

@en

prefLabel

Microfluidic platform for comb ...... oparticles for cancer therapy.

@ast

Microfluidic platform for comb ...... oparticles for cancer therapy.

@en

P1433

Q35038416-0153FFF3-8CA2-4E5F-8B81-6B4C2571B6FD

P1476

Q35038416-E2A19823-7152-41EC-AC9B-264C74CD9CAF

P2093

Q35038416-52F3033B-6B02-49F1-BF66-882CF5715D6A

Q35038416-73C97665-7C52-43AD-B88F-63C97A192F4F

Q35038416-AB16089F-EEA2-4379-B143-5E8038B5A922

Q35038416-BEC17406-12AE-42ED-830C-BBEB56840445

Q35038416-EC190A90-67D8-4752-A417-CC2EB7D92B3D

P2860

Q35038416-0BE0C5BB-F72F-453C-8CD9-C9B2AF743C63

Q35038416-2C38B4A0-5204-4719-8A67-8CE87ED83F99

Q35038416-2CE2868B-4E66-4753-89D0-48295954C2E5

Q35038416-34F121C5-9D9C-4C18-9292-65736CFA3336

Q35038416-37A154B1-4663-4915-A2EC-CFFF037177DB

Q35038416-42CDF6B7-0547-44F0-BC61-989659B8B55E

Q35038416-51D2F975-59DA-4890-B515-E550429E913E

Q35038416-540E7904-B055-4141-B23D-4BCD44128F9A

Q35038416-55B089E6-777D-4E3B-AC13-B87A9FEFCB8E

Q35038416-60460B5A-ADBC-48C9-990C-456638F8F002

P304

Q35038416-4109718A-DAFE-4094-BC6D-731B587FEAA8

P31

Q35038416-7936F207-8F1C-4000-A9BC-B1E439DCC984

P356

Q35038416-B4DF9976-FDBD-47F8-9FAF-C1A6AA25DCB7

P407

Q35038416-13F46F45-CDA4-46E4-B1DB-463676AEBACF

P433

Q35038416-711DBD99-2C7C-4176-A035-8D49B0209A1D

P478

Q35038416-9F4D8B03-3F50-430B-B1C8-5B94B4E140C5

P50

Q35038416-FFA16DCD-F901-4D7E-884A-C4D6FDB81D69

P577

Q35038416-D0A2AEC6-FF4F-4CB4-B58D-666930306A82

P5875

Q35038416-4946EC3F-0AED-4731-A925-EA69DF11EFAA

P698

Q35038416-1D0FBED7-CF0C-44E4-B8F5-900BC55DBD85

P921

Q35038416-6E5F990C-D276-4A1C-B8CB-183A1C75EC35

Q35038416-C3A46697-FE0A-45E3-B301-F6ED6920AD0C

P932

Q35038416-8FBE111D-95A0-4302-B13E-81F6730CC5D5

P356

P1433

P1476

Microfluidic platform for comb ...... oparticles for cancer therapy.

@en

P2093

Eric M Pridgen

http://www.w3.org/2001/XMLSchema#string

Minsoung Rhee

http://www.w3.org/2001/XMLSchema#string

Pedro M Valencia

http://www.w3.org/2001/XMLSchema#string

Robert Langer

http://www.w3.org/2001/XMLSchema#string

Rohit Karnik

http://www.w3.org/2001/XMLSchema#string

P2860

The journey of a drug-carrier in the body: an anatomo-physiological perspective

Nanocarriers as an emerging platform for cancer therapy

The origins and the future of microfluidics

Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels

A rapid pathway toward a superb gene delivery system: programming structural and functional diversity into a supramolecular nanoparticle library.

Historical overview of chemical library design.

Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery.

PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics.

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Microfluidic technologies for accelerating the clinical translation of nanoparticles.

P304

10671-10680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NN403370E

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Omid C. Farokhzad

P577

2013-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258442865

http://www.w3.org/2001/XMLSchema#string

P698

24215426

http://www.w3.org/2001/XMLSchema#string

P921

P932

3963607

http://www.w3.org/2001/XMLSchema#string